CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis
Top Cited Papers
- 8 April 2016
- journal article
- research article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 15 (7), 673-684
- https://doi.org/10.1016/s1474-4422(16)00070-3
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Progress Update: Fluid and Imaging Biomarkers in Alzheimer’s DiseaseBiological Psychiatry, 2014
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's DiseaseThe New England Journal of Medicine, 2012
- YKL-40, a Marker of Simian Immunodeficiency Virus Encephalitis, Modulates the Biological Activity of Basic Fibroblast Growth FactorThe American Journal of Pathology, 2008
- The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: A simulation studyBMC Medical Research Methodology, 2008
- Identification of Novel Brain BiomarkersClinical Chemistry, 2006
- Alzheimer's diseaseThe Lancet, 2006
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Axon caliber related to neurofilaments and microtubules in sciatic nerve fibers of rats and miceThe Anatomical Record, 1970